Lintuzumab

Revision as of 20:21, 27 September 2011 by WikiBot (talk | contribs) (Protected "Lintuzumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
Jump to: navigation, search
Lintuzumab
Monoclonal antibody
Type?
SourceTemplate:Infobox drug/mab source
TargetCD33
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Lintuzumab

Articles

Most recent articles on Lintuzumab

Most cited articles on Lintuzumab

Review articles on Lintuzumab

Articles on Lintuzumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lintuzumab

Images of Lintuzumab

Photos of Lintuzumab

Podcasts & MP3s on Lintuzumab

Videos on Lintuzumab

Evidence Based Medicine

Cochrane Collaboration on Lintuzumab

Bandolier on Lintuzumab

TRIP on Lintuzumab

Clinical Trials

Ongoing Trials on Lintuzumab at Clinical Trials.gov

Trial results on Lintuzumab

Clinical Trials on Lintuzumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lintuzumab

NICE Guidance on Lintuzumab

NHS PRODIGY Guidance

FDA on Lintuzumab

CDC on Lintuzumab

Books

Books on Lintuzumab

News

Lintuzumab in the news

Be alerted to news on Lintuzumab

News trends on Lintuzumab

Commentary

Blogs on Lintuzumab

Definitions

Definitions of Lintuzumab

Patient Resources / Community

Patient resources on Lintuzumab

Discussion groups on Lintuzumab

Patient Handouts on Lintuzumab

Directions to Hospitals Treating Lintuzumab

Risk calculators and risk factors for Lintuzumab

Healthcare Provider Resources

Symptoms of Lintuzumab

Causes & Risk Factors for Lintuzumab

Diagnostic studies for Lintuzumab

Treatment of Lintuzumab

Continuing Medical Education (CME)

CME Programs on Lintuzumab

International

Lintuzumab en Espanol

Lintuzumab en Francais

Business

Lintuzumab in the Marketplace

Patents on Lintuzumab

Experimental / Informatics

List of terms related to Lintuzumab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Lintuzumab is a humanized monoclonal antibody used to treat cancer.

Cost Effectiveness of Lintuzumab

| group5 = Clinical Trials Involving Lintuzumab | list5 = Ongoing Trials on Lintuzumab at Clinical Trials.govTrial results on LintuzumabClinical Trials on Lintuzumab at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Lintuzumab | list6 = US National Guidelines Clearinghouse on LintuzumabNICE Guidance on LintuzumabNHS PRODIGY GuidanceFDA on LintuzumabCDC on Lintuzumab


| group7 = Textbook Information on Lintuzumab | list7 = Books and Textbook Information on Lintuzumab


| group8 = Pharmacology Resources on Lintuzumab | list8 = AND (Dose)}} Dosing of LintuzumabAND (drug interactions)}} Drug interactions with LintuzumabAND (side effects)}} Side effects of LintuzumabAND (Allergy)}} Allergic reactions to LintuzumabAND (overdose)}} Overdose information on LintuzumabAND (carcinogenicity)}} Carcinogenicity information on LintuzumabAND (pregnancy)}} Lintuzumab in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Lintuzumab


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Lintuzumab | list9 = AND (pharmacogenomics)}} Genetics of LintuzumabAND (pharmacogenomics)}} Pharmacogenomics of LintuzumabAND (proteomics)}} Proteomics of Lintuzumab


| group10 = Newstories on Lintuzumab | list10 = Lintuzumab in the newsBe alerted to news on LintuzumabNews trends on Lintuzumab


| group11 = Commentary on Lintuzumab | list11 = Blogs on Lintuzumab

| group12 = Patient Resources on Lintuzumab | list12 = Patient resources on LintuzumabDiscussion groups on LintuzumabPatient Handouts on LintuzumabDirections to Hospitals Treating LintuzumabRisk calculators and risk factors for Lintuzumab


| group13 = Healthcare Provider Resources on Lintuzumab | list13 = Symptoms of LintuzumabCauses & Risk Factors for LintuzumabDiagnostic studies for LintuzumabTreatment of Lintuzumab

| group14 = Continuing Medical Education (CME) Programs on Lintuzumab | list14 = CME Programs on Lintuzumab

| group15 = International Resources on Lintuzumab | list15 = Lintuzumab en EspanolLintuzumab en Francais

| group16 = Business Resources on Lintuzumab | list16 = Lintuzumab in the MarketplacePatents on Lintuzumab

| group17 = Informatics Resources on Lintuzumab | list17 = List of terms related to Lintuzumab


}}



Linked-in.jpg